You are currently viewing a new version of our website. To view the old version click .

Acute and Chronic Heart Failure: Biomarkers-Guided Therapy and Clinical Management

This special issue belongs to the section “Cardiology“.

Special Issue Information

Dear Colleagues,

The prevalence of heart failure is increasing and prognosis continues to be bad. Nowadays, the main challenges in heart failure are establishing the diagnosis and prognosis and choosing the best treatment. Biomarkers, as indicators of a biological state that can be measured, may play a prominent role in heart failure management. They have been used to understand heart failure pathogenesis, to improve diagnosis and to guide treatment, though with conflicting results. Although treatment of heart failure has improved prognosis in heart failure with reduced ejection fraction, that has not been the case in heart failure with preserved ejection fraction. However, biomarkers could be useful in identifying subgroup of patients in whom a treatment might be useful. This Special Issue aims to provide researchers with an opportunity to publish original research related to biomarkers in heart failure, both acute and chronic, with a particular focus on predictive, diagnostic or prognostic value of classic and novel biomarkers.

Dr. Nuria Farre
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Heart failure
  • Biomarkers
  • Prognosis
  • Treatment
  • Diagnosis
  • Epidemiology
  • Hospitalization

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
J. Clin. Med. - ISSN 2077-0383